微试云企业版
Published by:
Beijing CTSLtd
Description
微试云企业版 是微试平台（www.WeTrial.com）开发的移动端应用，为临床试验机构、申办方、CRO、SMO公司提供临床试验项目移动化协作解决方案，重点以项目为核心，基于底层工作的协作，把多方高效的连接起来，实现临床试验项目进度、质量、成本、文档、患者随访等方面的执行与管理，通过移动化、在线化、数据共享、多维度即时的分析和呈现，从一线执行，到基于数据的洞察，为临床试验项目实现近乎即时的动态信息呈现，大大提高了资源对接，项目执行效率和管理水平，节省成本，降低风险，并有效缩短研发周期。
Screenshots
微试云企业版 FAQ
-
Is 微试云企业版 free?
Yes, 微试云企业版 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 微试云企业版 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 微试云企业版 cost?
微试云企业版 is free.
-
What is 微试云企业版 revenue?
To get estimated revenue of 微试云企业版 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Romania yet.
Ratings History
微试云企业版 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
微试云企业版 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
大专家医生版
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
CSCO
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
N/A
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
药研社
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
O-Trial Plus
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
简研
|
Unlock
|
Unlock
|
0
|
|
5 days ago | |
随访易-专注患者临床试验管理
ePRO for Patient
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
医学科研云
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
Trial Ops
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
微试云企业版 Installs
Last 30 days
微试云企业版 Revenue
Last 30 days微试云企业版 Revenue and Downloads
Gain valuable insights into 微试云企业版 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing CTSLtd
- Languages
- Chinese
- Recent release
- 5.31.0 (2 weeks ago )
- Released on
- Mar 12, 2020 (4 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.